HK1018078A1 - Recombinant sendai virus - Google Patents

Recombinant sendai virus

Info

Publication number
HK1018078A1
HK1018078A1 HK99103083A HK99103083A HK1018078A1 HK 1018078 A1 HK1018078 A1 HK 1018078A1 HK 99103083 A HK99103083 A HK 99103083A HK 99103083 A HK99103083 A HK 99103083A HK 1018078 A1 HK1018078 A1 HK 1018078A1
Authority
HK
Hong Kong
Prior art keywords
sendai virus
recombinant sendai
virus
transfecting
regenerating
Prior art date
Application number
HK99103083A
Other languages
English (en)
Inventor
Yoshiyuki Nagai
Atsushi Kato
Fukashi Murai
Tsuneaki Sakata
Mamoru Hasegawa
Tatsuo Shioda
Original Assignee
Dnavec Research Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dnavec Research Inc filed Critical Dnavec Research Inc
Publication of HK1018078A1 publication Critical patent/HK1018078A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18811—Sendai virus
    • C12N2760/18841—Use of virus, viral particle or viral elements as a vector
    • C12N2760/18843—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18811—Sendai virus
    • C12N2760/18851—Methods of production or purification of viral material
    • C12N2760/18852—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
HK99103083A 1995-11-01 1999-07-17 Recombinant sendai virus HK1018078A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP28541795 1995-11-01
PCT/JP1996/003069 WO1997016539A1 (fr) 1995-11-01 1996-10-22 Virus sendai recombinant

Publications (1)

Publication Number Publication Date
HK1018078A1 true HK1018078A1 (en) 1999-12-10

Family

ID=17691258

Family Applications (1)

Application Number Title Priority Date Filing Date
HK99103083A HK1018078A1 (en) 1995-11-01 1999-07-17 Recombinant sendai virus

Country Status (11)

Country Link
US (2) US7101685B2 (xx)
EP (1) EP0863202B1 (xx)
KR (1) KR100525687B1 (xx)
CN (1) CN1143892C (xx)
AT (1) ATE470704T1 (xx)
AU (1) AU7335296A (xx)
CA (1) CA2236378C (xx)
DE (1) DE69638196D1 (xx)
DK (1) DK0863202T3 (xx)
HK (1) HK1018078A1 (xx)
WO (1) WO1997016539A1 (xx)

Families Citing this family (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE470704T1 (de) * 1995-11-01 2010-06-15 Dnavec Research Inc Rekombinantes sendai-virus
PT997297E (pt) * 1998-05-18 2003-08-29 Seiko Epson Corp Impressora a jacto de tinta e seu cartucho de tinta
DE69940848D1 (de) * 1998-07-03 2009-06-18 Dnavec Research Inc (-)-strang rns virusvektor für nervenzellen
US7241617B2 (en) * 1998-07-03 2007-07-10 Dnavec Research, Inc. Sendai viral vectors comprising foreign genes inserted between the R1 and R2 Loci
US6828138B1 (en) * 1998-08-11 2004-12-07 Dnavec Research Inc. Recombinant sendai virus vector including a gene encoding a chemokine
US6544785B1 (en) 1998-09-14 2003-04-08 Mount Sinai School Of Medicine Of New York University Helper-free rescue of recombinant negative strand RNA viruses
US6514728B1 (en) 1998-11-09 2003-02-04 Nippon Biocaptal Limited Process for preparation of cytokines using Sendai virus expression system
US6490775B1 (en) * 1999-04-23 2002-12-10 Veri-Tek Inc. Press operation verification system
US20030166252A1 (en) * 1999-05-18 2003-09-04 Kaio Kitazato Paramyxovirus-derived RNP
KR20070058607A (ko) * 1999-05-18 2007-06-08 가부시키가이샤 디나벡크 겐큐쇼 엔벨로프 유전자 결손 파라믹소과 바이러스 벡터
US7226786B2 (en) 1999-05-18 2007-06-05 Dnavec Research Inc. Envelope gene-deficient Paramyxovirus vector
JP3748535B2 (ja) 1999-09-06 2006-02-22 株式会社ディナベック研究所 改変された転写開始配列を有するパラミクソウイルス
JP4838962B2 (ja) * 1999-11-02 2011-12-14 株式会社ディナベック研究所 気道上皮細胞への外因性遺伝子導入用組換えセンダイウイルスベクター
ATE351915T1 (de) 1999-11-02 2007-02-15 Dnavec Research Inc Rekombinanter sendaivirus-vektor für die einführung von fremdgenen ins epithel der atemwege
US7314614B1 (en) 1999-11-02 2008-01-01 Dnavec Research, Inc. Recombinant sendai virus vector for introducing exogenous genes to airway epithelia
EP1251174A4 (en) * 2000-01-19 2003-05-02 Dnavec Research Inc USE OF A PARAMYXOVIRUS VECTOR FOR GENTE TRANSFER IN BLOOD VESSELS
KR100854917B1 (ko) * 2000-03-30 2008-08-27 가부시키가이샤 디나벡크 겐큐쇼 센다이바이러스 벡터를 사용한 ａｉｄｓ 바이러스 백신
JP2001275684A (ja) * 2000-03-31 2001-10-09 Nippon Medical Research Kk 組換え体イヌジステンパーウイルスおよびその作製方法
CA2322057A1 (en) 2000-05-18 2001-11-18 Dnavec Research Inc. Paramyxovirus vectors used for transfer of foreign genes
WO2001092508A1 (fr) * 2000-06-01 2001-12-06 Dnavec Research Inc. Vecteur de retrovirus de pseudo-type contenant une proteine de membrane possedant une activite d'hemagglutinine
AU2001264824A1 (en) * 2000-06-01 2001-12-11 St. Jude Children's Research Hospital Vaccine and gene therapy vector and methods of use thereof
WO2002000264A1 (fr) * 2000-06-27 2002-01-03 Dnavec Research Inc. Vecteur de virus pour transfert de gene dans des cellules renales
US20040053877A1 (en) * 2000-10-06 2004-03-18 Masayuki Fukumura Paramyxovirus vector for transfering foreign gene into skeletal muscle
JP2002142770A (ja) * 2000-11-08 2002-05-21 Dnavec Research Inc 循環系への遺伝子送達用パラミクソウイルスベクター
KR100812884B1 (ko) 2000-11-27 2008-03-11 가부시키가이샤 디나벡크 겐큐쇼 혈관신생 유전자를 코드하는 파라믹소바이러스 벡터 및 그 이용
US6596206B2 (en) * 2001-03-30 2003-07-22 Picoliter Inc. Generation of pharmaceutical agent particles using focused acoustic energy
CA2482946C (en) 2002-04-26 2013-09-17 Medimmune Vaccines, Inc. Multi plasmid system for the production of influenza virus
US7465456B2 (en) 2002-04-26 2008-12-16 Medimmune, Llc Multi plasmid system for the production of influenza virus
JPWO2003092738A1 (ja) * 2002-04-30 2005-09-08 株式会社ディナベック研究所 ヘマグルチニン活性を低下させた薬剤または遺伝子運搬組成物
CN1675357A (zh) * 2002-06-03 2005-09-28 株式会社载体研究所 编码抗体的副粘病毒载体及其应用
EP1548101A4 (en) * 2002-09-04 2006-05-10 Dnavec Research Inc METHOD FOR PRODUCING A VIRAL VECTOR CONTAINING A MEMBRANE PROTEIN BINDING WITH THE NEURAMINIDASE FROM GRAM-POSITIVE BACTERIA TO SIALIC ACID AS AN INTEGRAL PART OF THE ENVELOPE
US20060104950A1 (en) * 2002-10-24 2006-05-18 Shinji Okano Methods of Tranducing genes into T cells
US7566458B2 (en) 2003-06-16 2009-07-28 Medimmune, Llc Influenza hemagglutinin and neuraminidase variants
US20070105208A1 (en) * 2003-06-30 2007-05-10 Jun You Minus strand rna virus vector carrying gene modified in high mutation region
US20070269414A1 (en) * 2003-11-04 2007-11-22 Shinji Okano Method for Producing Gene Transferred Denritic Cells
JP4771959B2 (ja) 2003-12-23 2011-09-14 メディミューン，エルエルシー インフルエンザウイルス作製のための多重プラスミド系
EP1712243A4 (en) 2004-01-13 2007-04-11 Dnavec Research Inc GENE THERAPY FOR TUMOR USING A NEGATIVE CHAIN RNA VIRAL VECTOR ENCODING AN IMMUNOSTIMULATORY CYTOKINE
CN1934260B (zh) 2004-01-22 2013-03-13 株式会社载体研究所 利用含有巨细胞病毒增强子和鸡β-肌动蛋白启动子的杂合启动子制造负链RNA病毒载体的方法
US20070141705A1 (en) * 2004-01-22 2007-06-21 Makoto Inoue Method for producing viral vectors
CA2560046A1 (en) * 2004-03-16 2005-09-22 Dnavec Research Inc. Methods for suppressing tumor proliferation
US20080038234A1 (en) * 2004-03-23 2008-02-14 Shuji Hayashi Bone Marrow-Related Cells Associated With Tissue Maintenance And/Or Repair
CA2568015C (en) 2004-05-25 2013-08-27 Medimmune Vaccines, Inc. Influenza hemagglutinin and neuraminidase variants
WO2006001122A1 (ja) 2004-06-24 2006-01-05 Dnavec Research Inc. Rnaウイルスが導入された樹状細胞を含む抗癌剤
DE102005006388A1 (de) 2005-02-11 2006-08-24 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Replikationsdefiziente RNA-Viren als Impfstoffe
ES2527503T3 (es) 2005-03-08 2015-01-26 Medimmune, Llc Virus influenza reordenantes
WO2006134917A1 (ja) 2005-06-14 2006-12-21 Dnavec Corporation 抗体の作製方法
EP2993235B1 (en) 2005-10-28 2019-02-13 ID Pharma Co., Ltd. Gene transfer into airway epithelial stem cell by using simian lentiviral vector pseudotyped with sendai rna virus spike protein
JPWO2007083644A1 (ja) * 2006-01-17 2009-06-11 ディナベック株式会社 新規タンパク質発現系
US20090246170A1 (en) 2006-05-31 2009-10-01 Dnavec Corporation Therapeutic Agent For Alzheimer's Disease
KR20090052857A (ko) * 2006-07-13 2009-05-26 디나벡크 가부시키가이샤 비복제형 파라믹소바이러스과 바이러스 벡터
WO2008133701A1 (en) 2006-07-21 2008-11-06 Medimmune, Llc. Methods and compositions for increasing replication capacity of an influenza virus
CA2659267C (en) 2006-08-09 2016-12-13 Medimmune, Llc Influenza hemagglutinin and neuraminidase variants
US20110021600A1 (en) 2006-09-04 2011-01-27 Kyowa Hakko Kirin Co., Ltd. Novel nucleic acid
WO2008100292A2 (en) 2006-10-16 2008-08-21 Genelux Corporation Modified vaccinia virus strains for use in diagnostic and therapeutic methods
EP2123752A4 (en) 2006-12-18 2010-08-11 Kyowa Hakko Kirin Co Ltd NOVEL NUCLEIC ACID
JPWO2008096811A1 (ja) 2007-02-07 2010-05-27 ディナベック株式会社 弱毒化マイナス鎖ｒｎａウイルス
US9145564B2 (en) * 2007-04-13 2015-09-29 National Institute Of Advanced Industrial Science And Technology Persistently infective Sendai virus vector
EP2143794A1 (en) 2007-04-27 2010-01-13 Kyushu University, National University Corporation Viral vector for gene therapy
ES2523587T3 (es) 2007-06-18 2014-11-27 Medimmune, Llc Virus influenza B que tienen alteraciones en el polipéptido hemaglutinina
US20100305188A1 (en) 2007-10-03 2010-12-02 Kyowa Hakko Kirin Co., Ltd. Nucleic acid capable of regulating the proliferation of cell
JPWO2009148137A1 (ja) 2008-06-04 2011-11-04 協和発酵キリン株式会社 肥満細胞の脱顆粒を制御する核酸
WO2010006144A2 (en) 2008-07-11 2010-01-14 Medlmmune, Llc. Influenza hemagglutinin and neuraminidase variants
CA2731007A1 (en) 2008-07-16 2010-01-21 Dnavec Corporation Method for production of reprogrammed cell using chromosomally unintegrated virus vector
WO2010050586A1 (ja) 2008-10-31 2010-05-06 ディナベック株式会社 組み換え蛋白質の発現を増強する方法
RU2535970C2 (ru) 2009-02-12 2014-12-20 МЕДИММЬЮН, ЭлЭлСи Варианты гемагглютинина и нейраминидазы гриппа
JP2009268471A (ja) * 2009-08-07 2009-11-19 Dnavec Research Inc センダイウイルスベクターを用いたワクチンおよびワクチンタンパク質
US8945576B2 (en) 2010-01-08 2015-02-03 Kyoto University Vaccine for treatment of tautopathy
CN103189508B (zh) 2010-08-30 2016-08-10 生物载体株式会社 用于诱导多能性干细胞的组合物及其用途
CN102205118B (zh) * 2011-03-25 2013-05-22 天津济命生生物科技有限公司 一种生物制品及其制备方法
US9637758B2 (en) 2011-04-28 2017-05-02 St. Jude Children's Research Hospital Modified Sendai virus vaccine and imaging vector
US9951349B2 (en) * 2011-09-27 2018-04-24 Yale University Compositions and methods for transient expression of recombinant RNA
RU2519763C9 (ru) * 2012-11-26 2015-04-27 Ольга Вячеславовна Матвеева Метод иммунотерапии онкологических заболеваний и фармацевтические композиции на основе онколитического вируса сендай
JP6543194B2 (ja) 2013-09-24 2019-07-10 株式会社Ｉｄファーマ 多能性幹細胞の誘導効率を改善する方法
EP3542818A4 (en) 2016-11-17 2020-07-29 Japan as Represented by The Director-General of National Institute of Infectious Diseases VACCINE AGAINST INFECTIOUS DISEASES USING NON-INFECTIOUS PARAMYXOVIRUS PARTICLES
CA3070552A1 (en) 2017-07-21 2019-01-24 I'rom Group Co., Ltd. Polynucleotide for modifying target sequence and use thereof
CN112135908A (zh) 2018-01-22 2020-12-25 国立传染病研究所长代表日本国 选择性cd8阳性t细胞诱导疫苗抗原
CN112538498B (zh) * 2020-04-20 2023-04-25 梅尔顿(深圳)生物医药技术有限公司 重组仙台病毒的构建方法及其应用
CN116018402A (zh) 2020-09-04 2023-04-25 心脏康复株式会社 iPS细胞的品质改善剂、iPS细胞的制备方法、iPS细胞、及iPS细胞制备用组合物
CA3203232A1 (en) 2020-12-25 2022-06-30 Kyoto University Method for producing naive human ips cells from somatic cells
WO2023227758A1 (en) 2022-05-25 2023-11-30 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Vaccine with reduced anti-vector antigenicity

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5217879A (en) * 1989-01-12 1993-06-08 Washington University Infectious Sindbis virus vectors
US5166057A (en) * 1989-08-28 1992-11-24 The Mount Sinai School Of Medicine Of The City University Of New York Recombinant negative strand rna virus expression-systems
AU7007491A (en) * 1990-02-02 1991-08-08 Schweiz. Serum- & Impfinstitut Bern Cdna corresponding to the genome of negative-strand rna viruses, and process for the production of infectious negative-strand rna viruses
JP3029272B2 (ja) * 1990-05-29 2000-04-04 邦忠 下遠野 構造蛋白質遺伝子、組換えベクター、組換えウイルス、ポリペプチドおよびポリペプチドの製造方法
US5665362A (en) * 1990-09-25 1997-09-09 Cantab Pharmaceuticals Research Limited Viral vaccines
US5173414A (en) * 1990-10-30 1992-12-22 Applied Immune Sciences, Inc. Production of recombinant adeno-associated virus vectors
US5318898A (en) * 1991-04-02 1994-06-07 Genetics Institute, Inc. Production of recombinant bone-inducing proteins
JPH0585943A (ja) * 1991-07-18 1993-04-06 Tonen Corp 組換えワクシニアウイルスを用いる非ａ非ｂ型肝炎ウイルス遺伝子の発現および非ａ非ｂ型肝炎ワクチン
US5445953A (en) * 1991-08-26 1995-08-29 Immuno Aktiengesellschaft Direct molecular cloning of a modified poxvirus genome
JPH05301895A (ja) * 1992-04-22 1993-11-16 Nippon Zeon Co Ltd ハイブリッド抗原タンパク質、それを発現する組み換えウイルス、及びその製造方法
ZA937164B (en) 1992-09-28 1994-05-23 Commw Scient Ind Res Org Delivery system
EP0702085B2 (en) * 1994-07-18 2010-01-13 Conzelmann, Karl-Klaus, Prof. Dr. Recombinant infectious non-segmented negative strand RNA virus
US5716821A (en) * 1994-09-30 1998-02-10 Uab Research Foundation Prevention and treatment of respiratory tract disease
US5789229A (en) 1994-09-30 1998-08-04 Uab Research Foundation Stranded RNA virus particles
DK0780475T4 (da) 1995-08-09 2006-10-23 Schweiz Serum & Impfinst Fremgangsmåde til fremstilling af infektiöse negativ-streng RNA-virus
DE69634904T2 (de) * 1995-10-31 2006-05-18 Dnavec Research Inc., Tsukuba Negativstrand rna virus mit selbständiger replikationsaktivität
ATE470704T1 (de) * 1995-11-01 2010-06-15 Dnavec Research Inc Rekombinantes sendai-virus
AU2749297A (en) 1996-05-01 1997-11-19 Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services, The Generation of viral transfectants using recombinant DNA-derived nucleoc apsid proteins
AT405939B (de) 1997-02-24 1999-12-27 Immuno Ag Verfahren zur inaktivierung von lipidumhüllten viren
US6231868B1 (en) * 1997-09-30 2001-05-15 University Of Maryland-Biotechnology Institute Method for generating nonpathogenic infections birnavirus from synthetic RNA transcripts
US7241617B2 (en) * 1998-07-03 2007-07-10 Dnavec Research, Inc. Sendai viral vectors comprising foreign genes inserted between the R1 and R2 Loci
US6828138B1 (en) 1998-08-11 2004-12-07 Dnavec Research Inc. Recombinant sendai virus vector including a gene encoding a chemokine
US6514728B1 (en) * 1998-11-09 2003-02-04 Nippon Biocaptal Limited Process for preparation of cytokines using Sendai virus expression system
US7226786B2 (en) * 1999-05-18 2007-06-05 Dnavec Research Inc. Envelope gene-deficient Paramyxovirus vector
US20030166252A1 (en) * 1999-05-18 2003-09-04 Kaio Kitazato Paramyxovirus-derived RNP
EP1251174A4 (en) * 2000-01-19 2003-05-02 Dnavec Research Inc USE OF A PARAMYXOVIRUS VECTOR FOR GENTE TRANSFER IN BLOOD VESSELS
KR100854917B1 (ko) * 2000-03-30 2008-08-27 가부시키가이샤 디나벡크 겐큐쇼 센다이바이러스 벡터를 사용한 ａｉｄｓ 바이러스 백신
CA2322057A1 (en) * 2000-05-18 2001-11-18 Dnavec Research Inc. Paramyxovirus vectors used for transfer of foreign genes
WO2002000264A1 (fr) * 2000-06-27 2002-01-03 Dnavec Research Inc. Vecteur de virus pour transfert de gene dans des cellules renales
US20040053877A1 (en) * 2000-10-06 2004-03-18 Masayuki Fukumura Paramyxovirus vector for transfering foreign gene into skeletal muscle
KR100812884B1 (ko) * 2000-11-27 2008-03-11 가부시키가이샤 디나벡크 겐큐쇼 혈관신생 유전자를 코드하는 파라믹소바이러스 벡터 및 그 이용
US20060104950A1 (en) 2002-10-24 2006-05-18 Shinji Okano Methods of Tranducing genes into T cells
WO2004067752A1 (ja) 2003-01-31 2004-08-12 Dnavec Research Inc. リボザイムをコードするパラミクソウイルスベクターおよびその利用
US20070105208A1 (en) * 2003-06-30 2007-05-10 Jun You Minus strand rna virus vector carrying gene modified in high mutation region
US20070269414A1 (en) 2003-11-04 2007-11-22 Shinji Okano Method for Producing Gene Transferred Denritic Cells
EP1712243A4 (en) * 2004-01-13 2007-04-11 Dnavec Research Inc GENE THERAPY FOR TUMOR USING A NEGATIVE CHAIN RNA VIRAL VECTOR ENCODING AN IMMUNOSTIMULATORY CYTOKINE
US20070141705A1 (en) * 2004-01-22 2007-06-21 Makoto Inoue Method for producing viral vectors
CN1934260B (zh) * 2004-01-22 2013-03-13 株式会社载体研究所 利用含有巨细胞病毒增强子和鸡β-肌动蛋白启动子的杂合启动子制造负链RNA病毒载体的方法
US20080038234A1 (en) * 2004-03-23 2008-02-14 Shuji Hayashi Bone Marrow-Related Cells Associated With Tissue Maintenance And/Or Repair
WO2006001122A1 (ja) * 2004-06-24 2006-01-05 Dnavec Research Inc. Rnaウイルスが導入された樹状細胞を含む抗癌剤

Also Published As

Publication number Publication date
KR100525687B1 (ko) 2005-11-25
DK0863202T3 (da) 2010-09-27
EP0863202B1 (en) 2010-06-09
WO1997016539A1 (fr) 1997-05-09
KR19990067271A (ko) 1999-08-16
CN1207124A (zh) 1999-02-03
CA2236378A1 (en) 1997-05-09
US20020098576A1 (en) 2002-07-25
EP0863202A4 (en) 1999-03-03
ATE470704T1 (de) 2010-06-15
CN1143892C (zh) 2004-03-31
US20050266566A1 (en) 2005-12-01
EP0863202A1 (en) 1998-09-09
AU7335296A (en) 1997-05-22
US7442544B2 (en) 2008-10-28
US7101685B2 (en) 2006-09-05
CA2236378C (en) 2011-01-25
DE69638196D1 (de) 2010-07-22

Similar Documents

Publication Publication Date Title
HK1018078A1 (en) Recombinant sendai virus
HK1018287A1 (en) (-)-strand rna virus vector having autonomously replicating activity
WO1996013597A3 (en) Improved adenovirus and methods of use thereof
EP1312679B8 (en) Recombinant MVA virus, and the use thereof
PL333070A1 (en) Infectious clones of rna viruses and vaccines based on them
CA2104396A1 (en) Viral particles having altered host range
DE69637723D1 (de) Rekombinantes,virales vektorsystem
IL107862A0 (en) Recombinant viral vector system
EP0866721A4 (en) ADENOVIRAL TARGET VECTORS
WO1995027071A3 (en) An adenovirus supervector system
WO1997005255A3 (fr) Virus auxiliaires pour la preparation de vecteurs viraux recombinants
BR9711998A (pt) Herpesvìrus saimiri como vetor viral.
CA2037677A1 (en) Process for production of exogenous gene or its product in plant cells
WO2003025187A3 (en) Improvement of gene expression in vectors
AU5958694A (en) Synthetic herpes simplex virus promoters
DE69839269D1 (de) Infektiöse vektoren und pflanzenklone, die sich von turnip mosaikvirus herleiten
ES8703519A1 (es) Procedimiento para la formacion de hibridos celulares
FI98466B (fi) FSME-viruksen läntisen alatyypin eristettyjä DNA- ja RNA-molekyylejä, näitä sisältäviä vektoreita ja soluviljelmiä sekä menetelmä näiden koodittamien peptidien valmistamiseksi

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20141022